Sarnasp. j.

Manufacture of bread; manufacture of fresh pastry goods and cakes

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-05-24
Registered address
Reymonta 3, 64-800 Chodzież, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

  • 2025not filed
  • 202427/06/2025
  • 202326/06/2024
  • 202229/06/2023
  • 202107/07/2022
  • 202001/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 2.83mMedianUSD 837.89kAverageUSD 5.71m
Net profit
This companyUSD 549.95kMedianUSD 31.23kAverageUSD 515.98k
Operating costs
This companyUSD 2.26mMedianUSD 771.28kAverageUSD 5.06m
Assets
This companyUSD 277.93kMedianUSD 352.99kAverageUSD 3.98m

Ownership

Owner
Maria Sarnaage 74
Maria Jolanta Sarnaage 71
Wojciech Sarnaage 70

Manner of representation

All partners are authorised to represent the company. Making declarations of will on behalf of the company requires the joint action of all partners. Granting commercial procuration requires the consent of all partners, but any partner may revoke the commercial procuration individually.

Maria Jolanta Sarna, Maria Sarna and Wojciech Sarna – all partners share the same surname, so the structure looks family-owned.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $21,342.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,490
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,582
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,992

FAQ

Last updated: 2026-07-25